First Horizon Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$151K Sell
585
-18
-3% -$4.29K ﹤0.01% 597
2025
Q1
$135K Buy
603
+10
+2% +$2.33K ﹤0.01% 598
2024
Q4
$136K Buy
593
+439
+285% +$106K ﹤0.01% 611
2024
Q3
$37.6K Buy
154
+4
+3% +$894 ﹤0.01% 1110
2024
Q2
$28.7K Buy
150
+5
+3% +$1.01K ﹤0.01% 1146
2024
Q1
$28.7K Buy
145
+22
+18% +$4.03K ﹤0.01% 1202
2023
Q4
$21.2K Sell
123
-22
-15% -$3.38K ﹤0.01% 1319
2023
Q3
$21.4K Sell
145
-82
-36% -$14.8K ﹤0.01% 1230
2023
Q2
$49.6K Sell
227
-9
-4% -$2.01K ﹤0.01% 884
2023
Q1
$51.7K Sell
236
-52
-18% -$11.3K ﹤0.01% 864
2022
Q4
$59.9K Sell
288
-16
-5% -$3.52K ﹤0.01% 786
2022
Q3
$65K Sell
304
-38
-11% -$8.65K ﹤0.01% 745
2022
Q2
$71K Buy
342
+141
+70% +$30K ﹤0.01% 799
2022
Q1
$49K Sell
201
-88
-30% -$21.3K ﹤0.01% 650
2021
Q4
$74K Sell
289
-68
-19% -$17.6K ﹤0.01% 786
2021
Q3
$93K Buy
357
+309
+644% +$84.5K ﹤0.01% 695
2021
Q2
$11K Sell
48
-12
-20% -$2.52K ﹤0.01% 1323
2021
Q1
$11K Hold
60
﹤0.01% 1265
2020
Q4
$13K Buy
60
+12
+25% +$2.39K ﹤0.01% 1014
2020
Q3
$8K Buy
+48
New +$8.86K ﹤0.01% 1068
2019
Q3
Sell
-15
Closed -$2K 1622
2019
Q2
$2K Sell
15
-15
-50% -$1.66K ﹤0.01% 1400
2019
Q1
$3K Buy
30
+10
+50% +$1.03K ﹤0.01% 1348
2018
Q4
$2K Buy
+20
New +$2.14K ﹤0.01% 1391
2014
Q4
Sell
-16
Closed 1546
2014
Q3
$0 Hold
16
﹤0.01% 1577
2014
Q2
$0 Buy
+16
New +$793 ﹤0.01% 1549
2013
Q3
Sell
-252
Closed -$11K 1183
2013
Q2
$11K Buy
+252
New +$12K 0.01% 503

Other funds holding RMD

First Horizon Advisors's RMD Position: Q2 2025 in Review

First Horizon Advisors reduced its ResMed (RMD) stake by 3% in Q2 2025, selling an estimated $4.29K and leaving 585 shares worth $151K. The position accounts for ﹤0.01% of the portfolio, ranked #597.

First Horizon Advisors first reported a position in RMD in Q2 2013 and has held it in 26 quarters since. 920 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

  • First Horizon Advisors held 585 shares of ResMed worth $151K as of Q2 2025.
  • First Horizon Advisors sold 18 ResMed shares in Q2 2025, an estimated $4.29K.
  • ResMed made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #597 holding.
  • First Horizon Advisors first reported a position in ResMed in Q2 2013 and has held it in 26 quarters since.
  • 920 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.